Autopsy report · NCT01617213
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
Cause of deathOther
“Study is no longer needed as recent data have answered the primary hypotheses for this study.”
Life of this trial
- Registered 2 months after it had already started.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Virginia
- Sponsor type
- University, hospital or other
- Conditions
- Multiple Myeloma
- Interventions
- Melphalan; Lenalidomide
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
“Study team is no longer moving forward with this study.” - Study of Body Composition Methodology in Young Children (InfantPod)
“This study will not be conducted. A new study is replacing this one.” - Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
“No funding, time, or personnel to complete this study.” - Loop Drainage Versus Incision and Drainage for Abscesses
“Pilot study not necessary as new data has become available.” - Muscle, Essential Amino Acids, and eXercise in Heart Failure
“There is no longer any funding to support the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.